Global Liraglutide Market Insights, Forecast to 2026
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.
The application of Liraglutide
Liraglutide for the treatment of type 2 diabetes mellitus
Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in 'Type 2 diabetes: the management of type 2 diabetes'
Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.
Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.
The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.
Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Liraglutide 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Liraglutide 3900 industry.
Based on our recent survey, we have several different scenarios about the Liraglutide 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Liraglutide 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Liraglutide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Liraglutide market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Liraglutide market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Liraglutide market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Liraglutide market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Liraglutide market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Liraglutide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Liraglutide market.
The following manufacturers are covered in this report:
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.
The application of Liraglutide
Liraglutide for the treatment of type 2 diabetes mellitus
Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in 'Type 2 diabetes: the management of type 2 diabetes'
Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.
Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.
The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.
Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Liraglutide 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Liraglutide 3900 industry.
Based on our recent survey, we have several different scenarios about the Liraglutide 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Liraglutide 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Liraglutide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Liraglutide market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Liraglutide market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Liraglutide market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Liraglutide market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Liraglutide market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Liraglutide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Liraglutide market.
The following manufacturers are covered in this report:
- HEC Pharm
- Bachem
- Bharat Pharmaceuticals
- Kingpep Biotechnology
- Shenzhen JYMed Technology
- Wuxi Asiapeptide
- AmbioPharm
- ...
- Pills
- Liquid
- Hospital
- Drug Store
1 STUDY COVERAGE
1.1 Liraglutide Product Introduction
1.2 Market Segments
1.3 Key Liraglutide Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Liraglutide Market Size Growth Rate by Type
1.4.2 Pills
1.4.3 Liquid
1.5 Market by Application
1.5.1 Global Liraglutide Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Drug Store
1.6 Coronavirus Disease 2019 (Covid-19): Liraglutide Industry Impact
1.6.1 How the Covid-19 is Affecting the Liraglutide Industry
1.6.1.1 Liraglutide Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Liraglutide Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Liraglutide Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Liraglutide Market Size Estimates and Forecasts
2.1.1 Global Liraglutide Revenue 2015-2026
2.1.2 Global Liraglutide Sales 2015-2026
2.2 Liraglutide Market Size by Region: 2020 Versus 2026
2.2.1 Global Liraglutide Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Liraglutide Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL LIRAGLUTIDE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Liraglutide Sales by Manufacturers
3.1.1 Liraglutide Sales by Manufacturers (2015-2020)
3.1.2 Liraglutide Sales Market Share by Manufacturers (2015-2020)
3.2 Liraglutide Revenue by Manufacturers
3.2.1 Liraglutide Revenue by Manufacturers (2015-2020)
3.2.2 Liraglutide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Liraglutide Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Liraglutide Revenue in 2019
3.2.5 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Liraglutide Price by Manufacturers
3.4 Liraglutide Manufacturing Base Distribution, Product Types
3.4.1 Liraglutide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liraglutide Product Type
3.4.3 Date of International Manufacturers Enter into Liraglutide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Liraglutide Market Size by Type (2015-2020)
4.1.1 Global Liraglutide Sales by Type (2015-2020)
4.1.2 Global Liraglutide Revenue by Type (2015-2020)
4.1.3 Liraglutide Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Liraglutide Market Size Forecast by Type (2021-2026)
4.2.1 Global Liraglutide Sales Forecast by Type (2021-2026)
4.2.2 Global Liraglutide Revenue Forecast by Type (2021-2026)
4.2.3 Liraglutide Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Liraglutide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Liraglutide Market Size by Application (2015-2020)
5.1.1 Global Liraglutide Sales by Application (2015-2020)
5.1.2 Global Liraglutide Revenue by Application (2015-2020)
5.1.3 Liraglutide Price by Application (2015-2020)
5.2 Liraglutide Market Size Forecast by Application (2021-2026)
5.2.1 Global Liraglutide Sales Forecast by Application (2021-2026)
5.2.2 Global Liraglutide Revenue Forecast by Application (2021-2026)
5.2.3 Global Liraglutide Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Liraglutide by Country
6.1.1 North America Liraglutide Sales by Country
6.1.2 North America Liraglutide Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Liraglutide Market Facts & Figures by Type
6.3 North America Liraglutide Market Facts & Figures by Application
7 EUROPE
7.1 Europe Liraglutide by Country
7.1.1 Europe Liraglutide Sales by Country
7.1.2 Europe Liraglutide Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Liraglutide Market Facts & Figures by Type
7.3 Europe Liraglutide Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Liraglutide by Region
8.1.1 Asia Pacific Liraglutide Sales by Region
8.1.2 Asia Pacific Liraglutide Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Liraglutide Market Facts & Figures by Type
8.3 Asia Pacific Liraglutide Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Liraglutide by Country
9.1.1 Latin America Liraglutide Sales by Country
9.1.2 Latin America Liraglutide Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Liraglutide Market Facts & Figures by Type
9.3 Central & South America Liraglutide Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Liraglutide by Country
10.1.1 Middle East and Africa Liraglutide Sales by Country
10.1.2 Middle East and Africa Liraglutide Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Liraglutide Market Facts & Figures by Type
10.3 Middle East and Africa Liraglutide Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 HEC Pharm
11.1.1 HEC Pharm Corporation Information
11.1.2 HEC Pharm Description, Business Overview and Total Revenue
11.1.3 HEC Pharm Sales, Revenue and Gross Margin (2015-2020)
11.1.4 HEC Pharm Liraglutide Products Offered
11.1.5 HEC Pharm Recent Development
11.2 Bachem
11.2.1 Bachem Corporation Information
11.2.2 Bachem Description, Business Overview and Total Revenue
11.2.3 Bachem Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bachem Liraglutide Products Offered
11.2.5 Bachem Recent Development
11.3 Bharat Pharmaceuticals
11.3.1 Bharat Pharmaceuticals Corporation Information
11.3.2 Bharat Pharmaceuticals Description, Business Overview and Total Revenue
11.3.3 Bharat Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bharat Pharmaceuticals Liraglutide Products Offered
11.3.5 Bharat Pharmaceuticals Recent Development
11.4 Kingpep Biotechnology
11.4.1 Kingpep Biotechnology Corporation Information
11.4.2 Kingpep Biotechnology Description, Business Overview and Total Revenue
11.4.3 Kingpep Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Kingpep Biotechnology Liraglutide Products Offered
11.4.5 Kingpep Biotechnology Recent Development
11.5 Shenzhen JYMed Technology
11.5.1 Shenzhen JYMed Technology Corporation Information
11.5.2 Shenzhen JYMed Technology Description, Business Overview and Total Revenue
11.5.3 Shenzhen JYMed Technology Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shenzhen JYMed Technology Liraglutide Products Offered
11.5.5 Shenzhen JYMed Technology Recent Development
11.6 Wuxi Asiapeptide
11.6.1 Wuxi Asiapeptide Corporation Information
11.6.2 Wuxi Asiapeptide Description, Business Overview and Total Revenue
11.6.3 Wuxi Asiapeptide Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Wuxi Asiapeptide Liraglutide Products Offered
11.6.5 Wuxi Asiapeptide Recent Development
11.7 AmbioPharm
11.7.1 AmbioPharm Corporation Information
11.7.2 AmbioPharm Description, Business Overview and Total Revenue
11.7.3 AmbioPharm Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AmbioPharm Liraglutide Products Offered
11.7.5 AmbioPharm Recent Development
11.1 HEC Pharm
11.1.1 HEC Pharm Corporation Information
11.1.2 HEC Pharm Description, Business Overview and Total Revenue
11.1.3 HEC Pharm Sales, Revenue and Gross Margin (2015-2020)
11.1.4 HEC Pharm Liraglutide Products Offered
11.1.5 HEC Pharm Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Liraglutide Market Estimates and Projections by Region
12.1.1 Global Liraglutide Sales Forecast by Regions 2021-2026
12.1.2 Global Liraglutide Revenue Forecast by Regions 2021-2026
12.2 North America Liraglutide Market Size Forecast (2021-2026)
12.2.1 North America: Liraglutide Sales Forecast (2021-2026)
12.2.2 North America: Liraglutide Revenue Forecast (2021-2026)
12.2.3 North America: Liraglutide Market Size Forecast by Country (2021-2026)
12.3 Europe Liraglutide Market Size Forecast (2021-2026)
12.3.1 Europe: Liraglutide Sales Forecast (2021-2026)
12.3.2 Europe: Liraglutide Revenue Forecast (2021-2026)
12.3.3 Europe: Liraglutide Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Liraglutide Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Liraglutide Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Liraglutide Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Liraglutide Market Size Forecast by Region (2021-2026)
12.5 Latin America Liraglutide Market Size Forecast (2021-2026)
12.5.1 Latin America: Liraglutide Sales Forecast (2021-2026)
12.5.2 Latin America: Liraglutide Revenue Forecast (2021-2026)
12.5.3 Latin America: Liraglutide Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Liraglutide Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Liraglutide Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Liraglutide Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Liraglutide Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Liraglutide Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Liraglutide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Liraglutide Product Introduction
1.2 Market Segments
1.3 Key Liraglutide Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Liraglutide Market Size Growth Rate by Type
1.4.2 Pills
1.4.3 Liquid
1.5 Market by Application
1.5.1 Global Liraglutide Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Drug Store
1.6 Coronavirus Disease 2019 (Covid-19): Liraglutide Industry Impact
1.6.1 How the Covid-19 is Affecting the Liraglutide Industry
1.6.1.1 Liraglutide Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Liraglutide Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Liraglutide Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Liraglutide Market Size Estimates and Forecasts
2.1.1 Global Liraglutide Revenue 2015-2026
2.1.2 Global Liraglutide Sales 2015-2026
2.2 Liraglutide Market Size by Region: 2020 Versus 2026
2.2.1 Global Liraglutide Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Liraglutide Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL LIRAGLUTIDE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Liraglutide Sales by Manufacturers
3.1.1 Liraglutide Sales by Manufacturers (2015-2020)
3.1.2 Liraglutide Sales Market Share by Manufacturers (2015-2020)
3.2 Liraglutide Revenue by Manufacturers
3.2.1 Liraglutide Revenue by Manufacturers (2015-2020)
3.2.2 Liraglutide Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Liraglutide Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Liraglutide Revenue in 2019
3.2.5 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Liraglutide Price by Manufacturers
3.4 Liraglutide Manufacturing Base Distribution, Product Types
3.4.1 Liraglutide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liraglutide Product Type
3.4.3 Date of International Manufacturers Enter into Liraglutide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Liraglutide Market Size by Type (2015-2020)
4.1.1 Global Liraglutide Sales by Type (2015-2020)
4.1.2 Global Liraglutide Revenue by Type (2015-2020)
4.1.3 Liraglutide Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Liraglutide Market Size Forecast by Type (2021-2026)
4.2.1 Global Liraglutide Sales Forecast by Type (2021-2026)
4.2.2 Global Liraglutide Revenue Forecast by Type (2021-2026)
4.2.3 Liraglutide Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Liraglutide Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Liraglutide Market Size by Application (2015-2020)
5.1.1 Global Liraglutide Sales by Application (2015-2020)
5.1.2 Global Liraglutide Revenue by Application (2015-2020)
5.1.3 Liraglutide Price by Application (2015-2020)
5.2 Liraglutide Market Size Forecast by Application (2021-2026)
5.2.1 Global Liraglutide Sales Forecast by Application (2021-2026)
5.2.2 Global Liraglutide Revenue Forecast by Application (2021-2026)
5.2.3 Global Liraglutide Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Liraglutide by Country
6.1.1 North America Liraglutide Sales by Country
6.1.2 North America Liraglutide Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Liraglutide Market Facts & Figures by Type
6.3 North America Liraglutide Market Facts & Figures by Application
7 EUROPE
7.1 Europe Liraglutide by Country
7.1.1 Europe Liraglutide Sales by Country
7.1.2 Europe Liraglutide Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Liraglutide Market Facts & Figures by Type
7.3 Europe Liraglutide Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Liraglutide by Region
8.1.1 Asia Pacific Liraglutide Sales by Region
8.1.2 Asia Pacific Liraglutide Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Liraglutide Market Facts & Figures by Type
8.3 Asia Pacific Liraglutide Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Liraglutide by Country
9.1.1 Latin America Liraglutide Sales by Country
9.1.2 Latin America Liraglutide Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Liraglutide Market Facts & Figures by Type
9.3 Central & South America Liraglutide Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Liraglutide by Country
10.1.1 Middle East and Africa Liraglutide Sales by Country
10.1.2 Middle East and Africa Liraglutide Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Liraglutide Market Facts & Figures by Type
10.3 Middle East and Africa Liraglutide Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 HEC Pharm
11.1.1 HEC Pharm Corporation Information
11.1.2 HEC Pharm Description, Business Overview and Total Revenue
11.1.3 HEC Pharm Sales, Revenue and Gross Margin (2015-2020)
11.1.4 HEC Pharm Liraglutide Products Offered
11.1.5 HEC Pharm Recent Development
11.2 Bachem
11.2.1 Bachem Corporation Information
11.2.2 Bachem Description, Business Overview and Total Revenue
11.2.3 Bachem Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bachem Liraglutide Products Offered
11.2.5 Bachem Recent Development
11.3 Bharat Pharmaceuticals
11.3.1 Bharat Pharmaceuticals Corporation Information
11.3.2 Bharat Pharmaceuticals Description, Business Overview and Total Revenue
11.3.3 Bharat Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bharat Pharmaceuticals Liraglutide Products Offered
11.3.5 Bharat Pharmaceuticals Recent Development
11.4 Kingpep Biotechnology
11.4.1 Kingpep Biotechnology Corporation Information
11.4.2 Kingpep Biotechnology Description, Business Overview and Total Revenue
11.4.3 Kingpep Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Kingpep Biotechnology Liraglutide Products Offered
11.4.5 Kingpep Biotechnology Recent Development
11.5 Shenzhen JYMed Technology
11.5.1 Shenzhen JYMed Technology Corporation Information
11.5.2 Shenzhen JYMed Technology Description, Business Overview and Total Revenue
11.5.3 Shenzhen JYMed Technology Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shenzhen JYMed Technology Liraglutide Products Offered
11.5.5 Shenzhen JYMed Technology Recent Development
11.6 Wuxi Asiapeptide
11.6.1 Wuxi Asiapeptide Corporation Information
11.6.2 Wuxi Asiapeptide Description, Business Overview and Total Revenue
11.6.3 Wuxi Asiapeptide Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Wuxi Asiapeptide Liraglutide Products Offered
11.6.5 Wuxi Asiapeptide Recent Development
11.7 AmbioPharm
11.7.1 AmbioPharm Corporation Information
11.7.2 AmbioPharm Description, Business Overview and Total Revenue
11.7.3 AmbioPharm Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AmbioPharm Liraglutide Products Offered
11.7.5 AmbioPharm Recent Development
11.1 HEC Pharm
11.1.1 HEC Pharm Corporation Information
11.1.2 HEC Pharm Description, Business Overview and Total Revenue
11.1.3 HEC Pharm Sales, Revenue and Gross Margin (2015-2020)
11.1.4 HEC Pharm Liraglutide Products Offered
11.1.5 HEC Pharm Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Liraglutide Market Estimates and Projections by Region
12.1.1 Global Liraglutide Sales Forecast by Regions 2021-2026
12.1.2 Global Liraglutide Revenue Forecast by Regions 2021-2026
12.2 North America Liraglutide Market Size Forecast (2021-2026)
12.2.1 North America: Liraglutide Sales Forecast (2021-2026)
12.2.2 North America: Liraglutide Revenue Forecast (2021-2026)
12.2.3 North America: Liraglutide Market Size Forecast by Country (2021-2026)
12.3 Europe Liraglutide Market Size Forecast (2021-2026)
12.3.1 Europe: Liraglutide Sales Forecast (2021-2026)
12.3.2 Europe: Liraglutide Revenue Forecast (2021-2026)
12.3.3 Europe: Liraglutide Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Liraglutide Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Liraglutide Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Liraglutide Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Liraglutide Market Size Forecast by Region (2021-2026)
12.5 Latin America Liraglutide Market Size Forecast (2021-2026)
12.5.1 Latin America: Liraglutide Sales Forecast (2021-2026)
12.5.2 Latin America: Liraglutide Revenue Forecast (2021-2026)
12.5.3 Latin America: Liraglutide Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Liraglutide Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Liraglutide Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Liraglutide Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Liraglutide Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Liraglutide Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Liraglutide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Liraglutide Market Segments
Table 2. Ranking of Global Top Liraglutide Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Liraglutide Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pills
Table 5. Major Manufacturers of Liquid
Table 6. COVID-19 Impact Global Market: (Four Liraglutide Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Liraglutide Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Liraglutide Players to Combat Covid-19 Impact
Table 11. Global Liraglutide Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Liraglutide Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Liraglutide Sales by Regions 2015-2020 (K MT)
Table 14. Global Liraglutide Sales Market Share by Regions (2015-2020)
Table 15. Global Liraglutide Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Liraglutide Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Liraglutide Sales Share by Manufacturers (2015-2020)
Table 18. Global Liraglutide Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Liraglutide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide as of 2019)
Table 20. Liraglutide Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Liraglutide Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Liraglutide Price (2015-2020) (USD/MT)
Table 23. Liraglutide Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Liraglutide Product Type
Table 25. Date of International Manufacturers Enter into Liraglutide Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Liraglutide Sales by Type (2015-2020) (K MT)
Table 28. Global Liraglutide Sales Share by Type (2015-2020)
Table 29. Global Liraglutide Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Liraglutide Revenue Share by Type (2015-2020)
Table 31. Liraglutide Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Liraglutide Sales by Application (2015-2020) (K MT)
Table 33. Global Liraglutide Sales Share by Application (2015-2020)
Table 34. North America Liraglutide Sales by Country (2015-2020) (K MT)
Table 35. North America Liraglutide Sales Market Share by Country (2015-2020)
Table 36. North America Liraglutide Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Liraglutide Revenue Market Share by Country (2015-2020)
Table 38. North America Liraglutide Sales by Type (2015-2020) (K MT)
Table 39. North America Liraglutide Sales Market Share by Type (2015-2020)
Table 40. North America Liraglutide Sales by Application (2015-2020) (K MT)
Table 41. North America Liraglutide Sales Market Share by Application (2015-2020)
Table 42. Europe Liraglutide Sales by Country (2015-2020) (K MT)
Table 43. Europe Liraglutide Sales Market Share by Country (2015-2020)
Table 44. Europe Liraglutide Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Liraglutide Revenue Market Share by Country (2015-2020)
Table 46. Europe Liraglutide Sales by Type (2015-2020) (K MT)
Table 47. Europe Liraglutide Sales Market Share by Type (2015-2020)
Table 48. Europe Liraglutide Sales by Application (2015-2020) (K MT)
Table 49. Europe Liraglutide Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Liraglutide Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Liraglutide Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Liraglutide Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Liraglutide Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Liraglutide Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Liraglutide Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Liraglutide Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Liraglutide Sales Market Share by Application (2015-2020)
Table 58. Latin America Liraglutide Sales by Country (2015-2020) (K MT)
Table 59. Latin America Liraglutide Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Liraglutide Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Liraglutide Revenue Market Share by Country (2015-2020)
Table 62. Latin America Liraglutide Sales by Type (2015-2020) (K MT)
Table 63. Latin America Liraglutide Sales Market Share by Type (2015-2020)
Table 64. Latin America Liraglutide Sales by Application (2015-2020) (K MT)
Table 65. Latin America Liraglutide Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Liraglutide Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Liraglutide Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Liraglutide Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Liraglutide Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Liraglutide Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Liraglutide Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Liraglutide Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Liraglutide Sales Market Share by Application (2015-2020)
Table 74. HEC Pharm Corporation Information
Table 75. HEC Pharm Description and Major Businesses
Table 76. HEC Pharm Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. HEC Pharm Product
Table 78. HEC Pharm Recent Development
Table 79. Bachem Corporation Information
Table 80. Bachem Description and Major Businesses
Table 81. Bachem Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Bachem Product
Table 83. Bachem Recent Development
Table 84. Bharat Pharmaceuticals Corporation Information
Table 85. Bharat Pharmaceuticals Description and Major Businesses
Table 86. Bharat Pharmaceuticals Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Bharat Pharmaceuticals Product
Table 88. Bharat Pharmaceuticals Recent Development
Table 89. Kingpep Biotechnology Corporation Information
Table 90. Kingpep Biotechnology Description and Major Businesses
Table 91. Kingpep Biotechnology Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Kingpep Biotechnology Product
Table 93. Kingpep Biotechnology Recent Development
Table 94. Shenzhen JYMed Technology Corporation Information
Table 95. Shenzhen JYMed Technology Description and Major Businesses
Table 96. Shenzhen JYMed Technology Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Shenzhen JYMed Technology Product
Table 98. Shenzhen JYMed Technology Recent Development
Table 99. Wuxi Asiapeptide Corporation Information
Table 100. Wuxi Asiapeptide Description and Major Businesses
Table 101. Wuxi Asiapeptide Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Wuxi Asiapeptide Product
Table 103. Wuxi Asiapeptide Recent Development
Table 104. AmbioPharm Corporation Information
Table 105. AmbioPharm Description and Major Businesses
Table 106. AmbioPharm Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. AmbioPharm Product
Table 108. AmbioPharm Recent Development
Table 109. Global Liraglutide Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Liraglutide Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Liraglutide Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Liraglutide Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Liraglutide Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Liraglutide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Liraglutide Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Liraglutide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Liraglutide Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Liraglutide Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Liraglutide Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Liraglutide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Liraglutide Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Liraglutide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Liraglutide Players
Table 127. Liraglutide Customers List
Table 128. Liraglutide Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. Liraglutide Market Segments
Table 2. Ranking of Global Top Liraglutide Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Liraglutide Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pills
Table 5. Major Manufacturers of Liquid
Table 6. COVID-19 Impact Global Market: (Four Liraglutide Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Liraglutide Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Liraglutide Players to Combat Covid-19 Impact
Table 11. Global Liraglutide Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Liraglutide Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Liraglutide Sales by Regions 2015-2020 (K MT)
Table 14. Global Liraglutide Sales Market Share by Regions (2015-2020)
Table 15. Global Liraglutide Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Liraglutide Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Liraglutide Sales Share by Manufacturers (2015-2020)
Table 18. Global Liraglutide Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Liraglutide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide as of 2019)
Table 20. Liraglutide Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Liraglutide Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Liraglutide Price (2015-2020) (USD/MT)
Table 23. Liraglutide Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Liraglutide Product Type
Table 25. Date of International Manufacturers Enter into Liraglutide Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Liraglutide Sales by Type (2015-2020) (K MT)
Table 28. Global Liraglutide Sales Share by Type (2015-2020)
Table 29. Global Liraglutide Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Liraglutide Revenue Share by Type (2015-2020)
Table 31. Liraglutide Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Liraglutide Sales by Application (2015-2020) (K MT)
Table 33. Global Liraglutide Sales Share by Application (2015-2020)
Table 34. North America Liraglutide Sales by Country (2015-2020) (K MT)
Table 35. North America Liraglutide Sales Market Share by Country (2015-2020)
Table 36. North America Liraglutide Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Liraglutide Revenue Market Share by Country (2015-2020)
Table 38. North America Liraglutide Sales by Type (2015-2020) (K MT)
Table 39. North America Liraglutide Sales Market Share by Type (2015-2020)
Table 40. North America Liraglutide Sales by Application (2015-2020) (K MT)
Table 41. North America Liraglutide Sales Market Share by Application (2015-2020)
Table 42. Europe Liraglutide Sales by Country (2015-2020) (K MT)
Table 43. Europe Liraglutide Sales Market Share by Country (2015-2020)
Table 44. Europe Liraglutide Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Liraglutide Revenue Market Share by Country (2015-2020)
Table 46. Europe Liraglutide Sales by Type (2015-2020) (K MT)
Table 47. Europe Liraglutide Sales Market Share by Type (2015-2020)
Table 48. Europe Liraglutide Sales by Application (2015-2020) (K MT)
Table 49. Europe Liraglutide Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Liraglutide Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Liraglutide Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Liraglutide Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Liraglutide Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Liraglutide Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Liraglutide Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Liraglutide Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Liraglutide Sales Market Share by Application (2015-2020)
Table 58. Latin America Liraglutide Sales by Country (2015-2020) (K MT)
Table 59. Latin America Liraglutide Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Liraglutide Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Liraglutide Revenue Market Share by Country (2015-2020)
Table 62. Latin America Liraglutide Sales by Type (2015-2020) (K MT)
Table 63. Latin America Liraglutide Sales Market Share by Type (2015-2020)
Table 64. Latin America Liraglutide Sales by Application (2015-2020) (K MT)
Table 65. Latin America Liraglutide Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Liraglutide Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Liraglutide Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Liraglutide Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Liraglutide Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Liraglutide Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Liraglutide Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Liraglutide Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Liraglutide Sales Market Share by Application (2015-2020)
Table 74. HEC Pharm Corporation Information
Table 75. HEC Pharm Description and Major Businesses
Table 76. HEC Pharm Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. HEC Pharm Product
Table 78. HEC Pharm Recent Development
Table 79. Bachem Corporation Information
Table 80. Bachem Description and Major Businesses
Table 81. Bachem Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Bachem Product
Table 83. Bachem Recent Development
Table 84. Bharat Pharmaceuticals Corporation Information
Table 85. Bharat Pharmaceuticals Description and Major Businesses
Table 86. Bharat Pharmaceuticals Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Bharat Pharmaceuticals Product
Table 88. Bharat Pharmaceuticals Recent Development
Table 89. Kingpep Biotechnology Corporation Information
Table 90. Kingpep Biotechnology Description and Major Businesses
Table 91. Kingpep Biotechnology Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Kingpep Biotechnology Product
Table 93. Kingpep Biotechnology Recent Development
Table 94. Shenzhen JYMed Technology Corporation Information
Table 95. Shenzhen JYMed Technology Description and Major Businesses
Table 96. Shenzhen JYMed Technology Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Shenzhen JYMed Technology Product
Table 98. Shenzhen JYMed Technology Recent Development
Table 99. Wuxi Asiapeptide Corporation Information
Table 100. Wuxi Asiapeptide Description and Major Businesses
Table 101. Wuxi Asiapeptide Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Wuxi Asiapeptide Product
Table 103. Wuxi Asiapeptide Recent Development
Table 104. AmbioPharm Corporation Information
Table 105. AmbioPharm Description and Major Businesses
Table 106. AmbioPharm Liraglutide Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. AmbioPharm Product
Table 108. AmbioPharm Recent Development
Table 109. Global Liraglutide Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Liraglutide Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Liraglutide Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Liraglutide Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Liraglutide Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Liraglutide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Liraglutide Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Liraglutide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Liraglutide Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Liraglutide Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Liraglutide Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Liraglutide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Liraglutide Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Liraglutide Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Liraglutide Players
Table 127. Liraglutide Customers List
Table 128. Liraglutide Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Liraglutide Product Picture
Figure 2. Global Liraglutide Sales Market Share by Type in 2020 & 2026
Figure 3. Pills Product Picture
Figure 4. Liquid Product Picture
Figure 5. Global Liraglutide Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Liraglutide Report Years Considered
Figure 9. Global Liraglutide Market Size 2015-2026 (US$ Million)
Figure 10. Global Liraglutide Sales 2015-2026 (K MT)
Figure 11. Global Liraglutide Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Liraglutide Sales Market Share by Region (2015-2020)
Figure 13. Global Liraglutide Sales Market Share by Region in 2019
Figure 14. Global Liraglutide Revenue Market Share by Region (2015-2020)
Figure 15. Global Liraglutide Revenue Market Share by Region in 2019
Figure 16. Global Liraglutide Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Liraglutide Revenue in 2019
Figure 18. Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Liraglutide Sales Market Share by Type (2015-2020)
Figure 20. Global Liraglutide Sales Market Share by Type in 2019
Figure 21. Global Liraglutide Revenue Market Share by Type (2015-2020)
Figure 22. Global Liraglutide Revenue Market Share by Type in 2019
Figure 23. Global Liraglutide Market Share by Price Range (2015-2020)
Figure 24. Global Liraglutide Sales Market Share by Application (2015-2020)
Figure 25. Global Liraglutide Sales Market Share by Application in 2019
Figure 26. Global Liraglutide Revenue Market Share by Application (2015-2020)
Figure 27. Global Liraglutide Revenue Market Share by Application in 2019
Figure 28. North America Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Liraglutide Sales Market Share by Country in 2019
Figure 31. North America Liraglutide Revenue Market Share by Country in 2019
Figure 32. U.S. Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Liraglutide Market Share by Type in 2019
Figure 37. North America Liraglutide Market Share by Application in 2019
Figure 38. Europe Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Liraglutide Sales Market Share by Country in 2019
Figure 41. Europe Liraglutide Revenue Market Share by Country in 2019
Figure 42. Germany Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Liraglutide Market Share by Type in 2019
Figure 53. Europe Liraglutide Market Share by Application in 2019
Figure 54. Asia Pacific Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Liraglutide Sales Market Share by Region in 2019
Figure 57. Asia Pacific Liraglutide Revenue Market Share by Region in 2019
Figure 58. China Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Liraglutide Market Share by Type in 2019
Figure 81. Asia Pacific Liraglutide Market Share by Application in 2019
Figure 82. Latin America Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Liraglutide Sales Market Share by Country in 2019
Figure 85. Latin America Liraglutide Revenue Market Share by Country in 2019
Figure 86. Mexico Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Liraglutide Market Share by Type in 2019
Figure 93. Latin America Liraglutide Market Share by Application in 2019
Figure 94. Middle East and Africa Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Liraglutide Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Liraglutide Revenue Market Share by Country in 2019
Figure 98. Turkey Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 103. UAE Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Liraglutide Market Share by Type in 2019
Figure 105. Middle East and Africa Liraglutide Market Share by Application in 2019
Figure 106. HEC Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Bachem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Bharat Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Kingpep Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Shenzhen JYMed Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Wuxi Asiapeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Figure 1. Liraglutide Product Picture
Figure 2. Global Liraglutide Sales Market Share by Type in 2020 & 2026
Figure 3. Pills Product Picture
Figure 4. Liquid Product Picture
Figure 5. Global Liraglutide Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Liraglutide Report Years Considered
Figure 9. Global Liraglutide Market Size 2015-2026 (US$ Million)
Figure 10. Global Liraglutide Sales 2015-2026 (K MT)
Figure 11. Global Liraglutide Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Liraglutide Sales Market Share by Region (2015-2020)
Figure 13. Global Liraglutide Sales Market Share by Region in 2019
Figure 14. Global Liraglutide Revenue Market Share by Region (2015-2020)
Figure 15. Global Liraglutide Revenue Market Share by Region in 2019
Figure 16. Global Liraglutide Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Liraglutide Revenue in 2019
Figure 18. Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Liraglutide Sales Market Share by Type (2015-2020)
Figure 20. Global Liraglutide Sales Market Share by Type in 2019
Figure 21. Global Liraglutide Revenue Market Share by Type (2015-2020)
Figure 22. Global Liraglutide Revenue Market Share by Type in 2019
Figure 23. Global Liraglutide Market Share by Price Range (2015-2020)
Figure 24. Global Liraglutide Sales Market Share by Application (2015-2020)
Figure 25. Global Liraglutide Sales Market Share by Application in 2019
Figure 26. Global Liraglutide Revenue Market Share by Application (2015-2020)
Figure 27. Global Liraglutide Revenue Market Share by Application in 2019
Figure 28. North America Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Liraglutide Sales Market Share by Country in 2019
Figure 31. North America Liraglutide Revenue Market Share by Country in 2019
Figure 32. U.S. Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Liraglutide Market Share by Type in 2019
Figure 37. North America Liraglutide Market Share by Application in 2019
Figure 38. Europe Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Liraglutide Sales Market Share by Country in 2019
Figure 41. Europe Liraglutide Revenue Market Share by Country in 2019
Figure 42. Germany Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Liraglutide Market Share by Type in 2019
Figure 53. Europe Liraglutide Market Share by Application in 2019
Figure 54. Asia Pacific Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Liraglutide Sales Market Share by Region in 2019
Figure 57. Asia Pacific Liraglutide Revenue Market Share by Region in 2019
Figure 58. China Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Liraglutide Market Share by Type in 2019
Figure 81. Asia Pacific Liraglutide Market Share by Application in 2019
Figure 82. Latin America Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Liraglutide Sales Market Share by Country in 2019
Figure 85. Latin America Liraglutide Revenue Market Share by Country in 2019
Figure 86. Mexico Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Liraglutide Market Share by Type in 2019
Figure 93. Latin America Liraglutide Market Share by Application in 2019
Figure 94. Middle East and Africa Liraglutide Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Liraglutide Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Liraglutide Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Liraglutide Revenue Market Share by Country in 2019
Figure 98. Turkey Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Liraglutide Sales Growth Rate (2015-2020) (K MT)
Figure 103. UAE Liraglutide Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Liraglutide Market Share by Type in 2019
Figure 105. Middle East and Africa Liraglutide Market Share by Application in 2019
Figure 106. HEC Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Bachem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Bharat Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Kingpep Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Shenzhen JYMed Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Wuxi Asiapeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Liraglutide Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Liraglutide Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
